REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY

被引：28

作者：

BROUWER, RML

FOLLATH, F

BUHLER, FR

机构：

[1] UNIV HOSP BASEL, KANTONSSPITAL, DIV CARDIOL, CH-4031 BASEL, SWITZERLAND

[2] UNIV HOSP BASEL, DIV CLIN PHARMACOL, CH-4031 BASEL, SWITZERLAND

来源：

关键词：

D O I：

10.1097/00005344-198507004-00008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S38 / S44

页数：7

共 69 条

[41] LESSEM J, 1982, ACTA MED SCAND, V681, P83
[42] LESSEM J, 1981, CALCIUM ANTAGONISTS, pS159
[43] LEWIS GRJ, 1978, NEW ZEAL MED J, V87, P351
[44] THE EFFECTS OF CALCIUM-CHANNEL BLOCKING-AGENTS ON CARDIOVASCULAR FUNCTION
LOW, RI
TAKEDA, P
MASON, DT
DEMARIA, AN
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (03) : 547 - 553
[45] MCGOURTY JC, 1984, BR J CLIN PHARM, V17, pP683
[46] MCINNES G, 1984, CALCIUM ANTAGONISTS, V62, P69
[47] MIDTBO K, 1980, CURR THER RES CLIN E, V27, P830
[48] COMPARATIVE CLINICAL ELECTROPHYSIOLOGIC EFFECTS OF DILTIAZEM, VERAPAMIL AND NIFEDIPINE - A REVIEW
MITCHELL, LB
SCHROEDER, JS
MASON, JW
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (03) : 629 - 635
[49] USE OF PROTEIN-A BEARING STAPHYLOCOCCUS-AUREUS IN ENZYME-IMMUNOASSAY (EIA)
MOTTOLESE, M
IACONA, A
NATALI, PG
[J]. IMMUNOLOGICAL COMMUNICATIONS, 1980, 9 (04): : 379 - 387
[50] ROLE OF NIFEDIPINE IN TREATMENT OF HYPERTENSION
MURPHY, MB
SCRIVEN, AJI
DOLLERY, CT
[J]. BRITISH MEDICAL JOURNAL, 1983, 287 (6387) : 257 - 259